The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.696%)
Open: 12.00
High: 12.75
Low: 12.00
Prev. Close: 12.00
SOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£1.16m Fundraising - Replacement

28 Nov 2011 12:32

RNS Number : 8925S
Orogen Gold PLC
28 November 2011
 



28 November 2011

 

Orogen Gold Plc

("Orogen" or "the Company")

Issue of Equity - REPLACEMENT

 

The following amendments have been made to the announcement entitled "Issue of Equity" released at 7.00 a.m. on 28 November 2011 (RNS No. 8424S):

 

·; The Company's total issued share capital following the completion of the Placing will consist of 1,905,172,453 ordinary shares of 0.1p each with one voting right per share and not 1,900,172,453 ordinary shares. 

 

·; The Placing Shares will represent approximately 12.13 per cent of the Company's enlarged share capital and not 12.17 per cent.

 

·; The percentage of each Director's interest in the issued capital of the Company following completion of the Placing will be:

 

Director

% of issued capital following completion of the Placing

John Barry

6.12

Ed Slowey

6.07

Alan Mooney

4.36

Michael Nolan

4.36

Adam Reynolds

4.90

 

 

All other information remains unchanged.

 

The full amended text appears below:

 

Orogen Gold Plc

("Orogen" or "the Company")

Issue of Equity

 

Orogen Gold Plc (AIM:ORE), the AIM listed mineral exploration company focussed on gold exploration and development of the Deli Jovan gold project in Serbia, announces that it has conditionally placed 231,160,000 new ordinary shares ("Placing Shares") of 0.1p each ("Ordinary Shares") with investors at a price of 0.5p per share thereby raising £1.16 million before costs (the "Placing"). The net proceeds from the Placing will provide additional working capital which will be used, inter alia, to finance further exploration expenditures on the Deli Jovan gold project.

 

The Placing Shares will represent approximately 12.13 per cent of the Company's enlarged share capital.

 

 

Background to and reasons for the Placing

 

Orogen Gold has an option to earn 55 per cent of the Deli Jovan gold project in Serbia from Canadian Listed (TSX-V) Reservoir Capital Corporation by committing CAD1.5 million (Canadian Dollars) of exploration expenditure on the project. The Company can earn a further 20 per cent by committing an additional CAD2 million of exploration expenditure on the project, which would bring Orogen's total interest in Deli Jovan to 75%.

 

The net proceeds of the Placing will be used, inter alia, to continue to finance the ongoing exploration expenditures associated with the Deli Jovan gold project. Together with existing cash resources the net proceeds of the Placing will enable the Company to complete the majority of the total earn-in to the Deli Jovan project.

 

The exploration programme has already achieved access to the historic underground mines at Gindusa and Rusman. The on-going work involves detailed mapping and sampling of the former mines to be followed in Spring 2012 by an initial diamond drilling programme on the property.

 

The net proceeds of the Placing will also enable the Directors to continue to seek opportunities to introduce a new project or projects to the Company. The Directors are seeking undervalued early-stage gold projects with considerable technical merit which have previously lacked management focus and which through effective exploration programmes provide a high probability to build value in the Company by making a successful commercial discovery.

 

 

Ed Slowey, Chief Executive of Orogen Gold comments:

 

"With our existing cash reserves and new funds raised we will be able to complete the majority of the earn-in at Deli Jovan including an initial diamond drilling programme."

 

"In the past twelve months we have accessed the two historic gold mines at Gindusa and Rusman. In particular the Gindusa mine workings show that this was a substantial mining operation in the past. The reopening work now facilitates underground mapping and sampling at both former mines which will be followed by a focused diamond drilling programme scheduled for Spring 2012."

 

"We have also completed detailed soil sampling along the Deli Jovan shear belt. This has identified several highly prospective new gold targets for exploration follow-up."

 

"We are delighted with our progress so far on the project, which is running to plan, and we anticipate further news over the coming months as our exploration programme progresses."

 

 

Directors' Participation

 

The Directors are participating in the Placing as follows:

 

Mr John Barry, director, has subscribed for 3,200,000 ordinary shares in the Company pursuant to the Placing. Following this subscription, Mr Barry is interested in 116,555,491 ordinary shares in the Company (representing approximately 6.12 per cent. of the issued share capital).

 

Mr Ed Slowey, director, has subscribed for 2,200,000 ordinary shares in the Company pursuant to the Placing. Following this subscription, Mr Slowey is interested in 115,555,491 ordinary shares in the Company (representing approximately 6.07 per cent. of the issued share capital).

 

Balvairde Capital Limited, a company in which both Mr Alan Mooney, director, and Mr Michael Nolan, director, have an interest, has subscribed for 7,400,000 ordinary shares in the Company pursuant to the Placing. Following this subscription, Mr Mooney is interested in 82,970,327 ordinary shares in the Company (representing approximately 4.36 per cent. of the issued share capital) and Mr Nolan is interested in 82,970,327 ordinary shares in the Company (representing approximately 4.36 per cent. of the issued share capital)

 

Diablo Consulting Limited, a company in which Mr Adam Reynolds, director, has an interest, has subscribed for 7,400,000 ordinary shares in the Company pursuant to the Placing. Following this subscription, Mr Reynolds is interested in 93,400,000 ordinary shares in the Company (representing approximately 4.90 per cent. of the issued share capital).

 

The Directors' participation in the Placing is a related party transaction under the AIM Rules. Since all of the Directors are participating in the Placing, there are no directors who are independent of the transaction. The Company's nominated adviser, Zeus Capital, considers the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Issue of the Placing Shares

 

The Placing is solely conditional upon admission of the Placing Shares to AIM ("Admission").

 

Application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM. It is expected that such Admission will become effective and that dealings will commence on or around 1 December 2011.

 

The Placing Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares, including the right to receive dividends and other distributions declared following Admission. 

 

 

Total Voting Rights

 

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following the completion of the Placing will consist of 1,905,172,453 ordinary shares of 0.1p each with one voting right per share. There are no shares held in treasury. 

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

 Enquiries:

 

Orogen Gold Plc

Ed Slowey, CEO

Alan Mooney, FD

 +353 1662 8395

 

Zeus Capital Limited

Nominated Adviser and Joint Broker

Ross Andrews/Tom Rowley 

+44 (0)161 831 1512

 

XCAP Securities Plc

Joint Broker

John Grant/Karen Kelly

+44 (0) 207 101 7070

 

Hansard

Financial PR

Guy McDougall/ Nicholas Nelson

+44 (0) 207 245 1100

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODMMMZMZRLGMZM
Date   Source Headline
16th Apr 20247:00 amRNSFull Year Trading Update
10th Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSBoard Changes
12th Dec 20237:00 amRNSHalf Year Results
29th Nov 20237:00 amRNSNotice of Results and Investor Presentations
9th Nov 20237:00 amRNSMello Investor Presentation
18th Oct 20237:00 amRNSTrading & Strategic Update
13th Oct 20237:00 amRNSNotice of Trading Update
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.